Please do not leave this page until complete. This can take a few moments.
Holliston’s Biostage has cut its losses down even as it prepares to launch human trials of its Cellframe organ implants.
The company announced second quarter losses of $2.7 million, which was down from $4.5 million for the second quarter of 2015. This news came as the organization increased research and development expenses by $600,000 year-over-year in the quarter up to $1.7 million, according to a release from the company. The company was able to cut general and administrative expenses to $1.2 million from $3.5 million in the same quarter of 2015.
"The second quarter of 2016 has proven to be the company's best execution and operational quarter to date, and I am thrilled with our progress. We advanced our clinical and regulatory strategy by executing on all fronts in earnest and have prepared Biostage for upcoming catalytic events, which we expect will drive value in the near-term,” Biostage CEO Jim McGorry said in a statement.
Chief among those upcoming events is potential human testing of the company’s bioengineered organ regeneration technology that has proven it can successfully recreate parts of a pig's esophagus. The small biotech company, with 22 employees, is in the process of putting together its investigational new drug (IND) filing with the U.S. Food and Drug Administration for Cellspan esophageal implants. If approved, human testing could begin in 2017.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments